Skip to main content
. 2024 Oct 5;18:4459–4469. doi: 10.2147/DDDT.S473080

Figure 4.

Figure 4

Cumulative fraction of response (CFR) for different dosage regimens of tigecycline for PK/PD targets with AUC/MIC ≥ 17.9 (A), 12.8 (B) and 6.96 (C). The MICs were determined based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) MIC distribution website. The dashed lines indicate a PTA of 90%.

Abbreviations: A. baumannii, Acinetobacter baumannii; E. faecium, Enterococcus faecium; E. coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; MRSA, methicillin-resistant Staphylococcus aureus.